Next 10 |
2024-07-21 21:02:13 ET More on health care stocks Elevance Health: Buy A Dividend Growth Machine Elevance extends losses as BofA cuts on Medicaid headwinds What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Merck: Among The Best Health Ca...
2024-07-21 07:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Bristol-Myers Squibb - Investors Are Too Long-Term Focused Bristol-Myers Squibb Is A Bargain Now AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings Dividend Roundup: Gold...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-20 07:04:09 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-07-19 10:15:54 ET Summary On July 18, Novartis AG released its second-quarter 2024 financial results, which were solid. The company's free cash flow was about $4.62 billion for the second quarter of 2024, up 40% year over year, primarily due to strong sales of its oncology fr...
2024-07-19 08:05:17 ET This week's dividend activity included increased payouts from Goldman Sachs ( NYSE: GS ) and Duke Energy ( DUK ) as well as declarations from companies like Johnson & Johnson ( NYSE: JNJ ) and Qualcomm ( NASDAQ: QCOM ).... Read th...
2024-07-18 18:00:00 ET Summary Building a dividend portfolio from scratch is not an easy task, and it is crucial to ensure a reduced overall risk level to prioritize capital preservation. In this article, I will demonstrate how you could allocate the amount of $100,000 following t...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 12:57:51 ET Summary Dividends matter in practice, despite academic theories suggesting otherwise. Dividends align incentives between management and shareholders, optimizing free cash flow growth and reducing agency costs. Dividend investing eliminates sequence risk ...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
News, Short Squeeze, Breakout and More Instantly...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...